Wolverine Asset Management LLC Pfizer Inc Put Options Transaction History

Wolverine Asset Management LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $5 Million - $5.75 Million	-193,300 Reduced 69.33%	85,500 $2.37 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $3.79 Million - $4.93 Million	145,200 Added 108.68%	278,800 $8.03 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $731,652 - $855,228	22,800 Added 20.58%	133,600 $4.43 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $2.63 Million - $3.04 Million	-72,800 Reduced 39.65%	110,800 $4.06 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $1.57 Million - $2.05 Million	39,900 Added 27.77%	183,600 $7.49 Million

Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $5.2 Million - $6.79 Million	124,500 Added 648.44%	143,700 $7.37 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $840,192 - $1.03 Million	19,200 New	19,200 $840,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $100,022 - $114,036	2,600 Added 14.44%	20,600 $899,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $3.32 Million - $3.85 Million	-104,000 Reduced 85.25%	18,000 $638,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $2.23 Million - $2.46 Million	72,000 Added 144.0%	122,000 $4.36 Million
Q2 2017 Aug 14, 2017	BUY	N/A	50,000	50,000 $1.68 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.